《半日總結》恆指跌461點 騰訊系股份受挫 美團下滑逾5%
美國10月份零售銷售超預期,惟大型零售商唱淡年底購物旺季前景,美股道指反覆收跌39點或0.12%。港股早市偏軟,恆指低開184點後跌勢持續並失守萬八點關,一度挫544點低見17,711點,中午收報17,794點,跌461點或2.5%;國指跌183點或2.9%,報6,042點;恆生科技指數下滑182點或4.8%,報3,622點。大市半日成交總額776.81億元,滬、深港通南下交易半日分別淨流入8.94億及30.58億元人民幣。
騰訊(00700.HK)跌2.3%報287.6元,公司第三季非國際財報準則純利升1.6%至322.54億人民幣勝預期,另分派美團(03690.HK)近9.6億股B股作特別中期息,美團股價跌5.7%。市場憂慮騰訊系股份將成下個分派或減持對象,騰訊系股份急挫,騰訊音樂(01698.HK)跌11.3%,名創優品(09896.HK)瀉14.3%,微盟(02013.HK)跌9.4%,蔚來(09866.HK)及創夢天地(01119.HK)跌逾8%,嗶哩嗶哩(09626.HK)跌7.4%,快手(01024.HK)5.5%。
其他科技股方面,阿里巴巴(09988.HK)將於今日(17日)披露季績,股價半日跌近4%,同系阿里健康(00241.HK)跌7.8%。網易(09999.HK)挫10.9%,為表現最差藍籌股,公司與暴雪娛樂現有授權合約將於明年1月到期,後者將在內地暫停大部分遊戲服務。百度(09888.HK)跌近6%。小米(01810.HK)及京東(09618.HK)各跌4.5%及3%。萬國數據(09698.HK)挫14.3%。
電動車股捱沽,小鵬(09868.HK)挫10.8%。理想(02015.HK)跌7.3%。其他車股吉利(00175.HK)及比亞迪(01211.HK)齊跌逾3%。
生物醫藥股受壓,樂普生物(02157.HK)跌近15%。再鼎醫藥(09688.HK)及心通醫療(02160.HK)分別跌6.8%。藥明生物(02269.HK)跌5.9%。中生製藥(01177.HK)跌3.3%。
重磅金融股方面,匯控(00005.HK)半日跌1.1%。港交所(00388.HK)跌2.4%。友邦(01299.HK)跌1.8%。此外,中升(00881.HK)跌8.4%,申洲(02313.HK)跌6.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.